Arcus Ventures logo

Arcus Ventures

North America, New York, United States, New York

Description

Founded in 2007, Arcus Ventures invests in oncology-focused companies with advanced biopharmaceuticals and is a private equity company.

Investor Profile

Arcus Ventures has made 22 investments, with 0 in the past 12 months and 18% as lead.

Stage Focus

  • Series B (32%)
  • Series A (23%)
  • Series C (18%)
  • Series Unknown (14%)
  • Series D (9%)
  • Series E (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Genetics
  • Medical Device
  • Manufacturing
  • Life Science
  • Pharmaceutical
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arcus Ventures frequently co-invest with?

NGN Capital
North America, New York, United States, New York
Co-Investments: 4
CC
North America, Massachusetts, United States, Boston
Co-Investments: 3
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 4
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 4
Physic Ventures
North America, California, United States, San Francisco
Co-Investments: 3
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 4
Flybridge
North America, Massachusetts, United States, Boston
Co-Investments: 3
WS Investments
North America, California, United States, Palo Alto
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 3

What are some of recent deals done by Arcus Ventures?

Cleave Therapeutics

San Francisco, California, United States

Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

BiopharmaBiotechnologyHealth Care
Series CAug 6, 2019
Amount Raised: $12,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJul 24, 2017
Amount Raised: $30,000,000
Cleave Therapeutics

San Francisco, California, United States

Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

BiopharmaBiotechnologyHealth Care
Series BAug 17, 2016
Amount Raised: $37,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BJan 7, 2016
Amount Raised: $16,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BSep 2, 2015
Amount Raised: $17,600,000
XTuit Pharmaceuticals

Cambridge, Massachusetts, United States

XTuit Pharmaceuticals develops pharmaceutical preparations for the diagnosis and treatment of oncological, tumor, and inflammatory diseases.

BiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical
Series AJun 11, 2015
Amount Raised: $22,000,000
TRACON Pharmaceuticals

San Diego, California, United States

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.

BiotechnologyHealth CareMedical Device
Series BSep 22, 2014
Amount Raised: $27,000,000
Epic Sciences

La Jolla, California, United States

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine
Series CJul 30, 2014
Amount Raised: $30,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BMar 11, 2014
Amount Raised: $27,000,000
MI Bioresearch

Ann Arbor, Michigan, United States

MI Bioresearch is a contract research organization providing in vivo preclinical imaging services.

BiotechnologyLife ScienceMedical
Series BOct 2, 2013
Amount Raised: $3,500,000